BIONIK LABORATORIES CORP. (BNKL) financial statements (2020 and earlier)

Company profile

Business Address 483 BAY STREET
TORONTO, ON M5G2C9
State of Incorp. DE
Fiscal Year End March 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2011700
Cash and cash equivalents2011700
Receivables02000  
Inventory, net of allowances, customer advances and progress billings1000  
Inventory1000   
Prepaid expense00000  
Other undisclosed current assets21000  
Total current assets:5411700
Noncurrent Assets
Property, plant and equipment00000  
Intangible assets, net (including goodwill)27272727  
Goodwill22222222   
Intangible assets, net (excluding goodwill)4455   
Total noncurrent assets:272727280  
TOTAL ASSETS:32312929700
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2322000
Accounts payable11110  
Accrued liabilities12210  
Other undisclosed accounts payable and accrued liabilities     00
Deferred revenue1
Debt0 01   
Deferred revenue and credits00   
Customer advances and deposits00  
Other undisclosed current liabilities 063 00
Total current liabilities:3386000
Noncurrent Liabilities
Other undisclosed liabilities    6  
Total liabilities:3386600
Stockholders' equity
Stockholders' equity attributable to parent, including:292720231(0)(0)
Common stock00000  
Additional paid in capital8474563911(0)(0)
Accumulated other comprehensive income00000  
Accumulated deficit(55)(46)(36)(16)(11)(0) 
Other undisclosed stockholders' equity attributable to parent    000
Total stockholders' equity:292720231(0)(0)
TOTAL LIABILITIES AND EQUITY:32312929700

Income statement (P&L) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
12/31/2015
12/31/2014
12/31/2013
Revenues0011000
Revenue, net11   
Other operating income00  0  
Cost of revenue(1)(2)(0)(0) (0) 
Cost of goods and services sold(1)(2)(0)(0)   
Other undisclosed gross profit23     
Gross profit:12100(0)0
Operating expenses(12)(11)(10)(9)(6)(0)(0)
Operating loss:(11)(9)(10)(9)(6)(0)(0)
Nonoperating income (expense)(1)(1)(5)91  
Investment income, nonoperating   40  
Other nonoperating income (expense)(1)(1)(5)50  
Interest and debt expense 0(1)(0)(0)  
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(0)(0)1(4)(1)  
Loss before gain (loss) on sale of properties:(12)(11)(15)(4)(6)(0)(0)
Other undisclosed net income4      
Net loss:(8)(11)(15)(4)(6)(0)(0)
Other undisclosed net income attributable to parent321     
Net income (loss) available to common stockholders, diluted:(5)11(15)(4)(6)(0)(0)

Comprehensive Income ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
12/31/2015
12/31/2014
12/31/2013
Net loss:(8)(11)(15)(4)(6)(0)(0)
Comprehensive loss:(8)(11)(15)(4)(6)(0)(0)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(4)   0  
Comprehensive loss, net of tax, attributable to parent:(12)(11)(15)(4)(6)(0)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: